Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection. - Wikidata - awgldk - TriplyDB

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

http://www.wikidata.org/entity/Q35847032

about

Native functionality and therapeutic targeting of arenaviral glycoproteins Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits Inflammatory monocytes hinder antiviral B cell responses.Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy.Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.Interferon-driven deletion of antiviral B cells at the onset of chronic infection.Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization.Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.Vaccine platforms to control Lassa fever.Structure-function relationship of the mammarenavirus envelope glycoprotein.Differential Immune Responses to New World and Old World Mammalian Arenaviruses.Pathogen-specific B-cell receptors drive chronic lymphocytic leukemia by light-chain-dependent cross-reaction with autoantigens.Structural basis for antibody-mediated neutralization of Lassa virus.Evolutionary analysis of Old World arenaviruses reveals a major adaptive contribution of the viral polymerase.Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies.Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities.Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.Arenaviral vaccine vectors to combat infectious diseases.Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.Exploiting glycan topography for computational design of Env glycoprotein antigenicity.Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.The Janus Face of Follicular T Helper Cells in Chronic Viral Infections.Structure of the Lassa virus glycan shield provides a model for immunological resistance Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever

P2860

Q26827679-0D75D36F-A721-4B3D-A18E-1250F4669A42 Q27704710-D23DC2B7-7B2A-4BC8-B151-1F5CA3D5DFA2 Q27728036-49723AF7-5AA8-4D9C-9728-0E4C45B389CF Q28602816-19EDA81B-D94F-4034-ACC4-E9F254FD42EF Q30828890-AAB49240-007B-4613-BFF8-E80A3FFBCA51 Q33762986-6FBBB407-B33A-41C6-BC45-3D9168233F5C Q36694022-A8AE2A84-27D1-4BAA-AE1C-03C6215D16EB Q37423183-9665BBA0-F3F2-4192-8F21-76CCF445A1C1 Q38718346-29C7177A-8303-4164-9787-4BB91DF7F108 Q38789279-B4B9E12E-CB0A-42A7-8B73-7FC76935DCC4 Q38823264-42718360-54AD-4FBD-87D9-E359672A8B2B Q38937488-40673686-C8D5-44F6-B6E1-DCBC4E89E167 Q39302482-31E9F4C1-CC46-4A99-8CAA-63189041874B Q40044803-6C07F2EB-F96E-4927-BF7D-EFBBAE3FA98D Q40054615-E15DEF42-60C2-4C83-A22B-E33FAE5A6C5E Q40093891-6E0202DD-4E24-44E9-B525-23F0F2737DE6 Q40255965-586088AE-85B1-4471-86BC-9CA4288F1693 Q40449526-B3E8149B-6E27-4842-B2B7-060E408DBAB4 Q41024937-3D131E76-6FD4-429D-B5A2-9EDD1026F68C Q41935553-6DE12F39-C43A-4469-B29E-181717791F11 Q42333574-89222915-4A34-4BC4-9D26-C330407A3C0E Q47548101-80015F0F-8906-49E5-B4CD-AE0524C5793F Q52314288-84A5CEC9-12B6-4D52-AFFE-2CE0A4967070 Q52717837-E2B48C7E-9B8B-4BC2-AD72-FAB40756659D Q54987756-4E1BB92C-2CC9-4792-9392-16CF6831B182 Q56941600-FB2F568E-CC55-4219-A12C-043A550455AB Q57476548-29223DC0-4B84-45F6-9F9A-9765E8F786FA

P2860

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

http://www.wikidata.org/entity/Q35847032

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

@ast

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

@en

type

label

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

@ast

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

@en

prefLabel

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

@ast

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

@en

P1433

Q35847032-B3ACF0C5-C747-47F9-BD78-D4797566014B

P1476

Q35847032-98C07E51-A38B-4C05-9E88-DF8906A3695E

P2093

Q35847032-037D4A49-4D72-46E3-B3B5-49E01032F053

Q35847032-0BF4C42F-E2B5-460B-B90E-EFCA1E43576F

Q35847032-0F8EEFB7-2E62-447E-B9AF-94D2EEE2FF98

Q35847032-10AF5AE4-518C-4D69-A961-C610A83B3636

Q35847032-3E42901C-BFE8-4BE3-9599-D4FA57E86DAB

Q35847032-5D5AE80D-1824-41AB-938B-18878807D4EF

Q35847032-5ED34BFA-8F7F-41C6-891A-60EB6BA98D8D

Q35847032-867B4DAA-CA43-4851-B5E9-9CE622EF46BD

Q35847032-A2B938FB-54D4-4EC3-ABE7-73AE9362A00F

Q35847032-A663B019-75CF-4584-B30C-AA6E02C96D95

P2860

Q35847032-0072D216-4A1B-4129-9204-CD1075681439

Q35847032-03C49660-C3CB-4D9B-9731-1A49E93BA65C

Q35847032-05D2B31C-E9D6-46B9-8574-1E8196AF061F

Q35847032-07CAC255-9F12-4D9C-9EDD-4D679AAB344F

Q35847032-0A1B84A0-71C4-46E8-99BA-422C8122A570

Q35847032-0A9C81D5-91B1-4D9C-A92F-E220CDE9E8CF

Q35847032-125C7EB6-9EF6-450C-BB9A-0F1AAB0E696D

Q35847032-13226B58-9479-4D40-B4A0-74700E57D1AE

Q35847032-17EC4AC6-F580-4190-9220-0147FF7A9BB8

Q35847032-1C5F2F0B-D3D8-4DE3-96EB-0DD5C5A27D03

P304

Q35847032-85CF5C05-A7D8-438E-98D5-1067B1636C0F

P31

Q35847032-D91773D9-EA01-420B-9942-391F385235CB

P356

Q35847032-A711605E-291F-47C0-B736-BE8C4F75D166

P433

Q35847032-F2F31DC9-9B6D-455D-B55C-CAB34EF6A41E

P478

Q35847032-C961BE16-2175-486E-B90F-EF4C0F6407E0

P50

Q35847032-23EDCEC8-888E-4D2F-8B4D-A2849B7F2192

Q35847032-3A5C5095-E4C6-4FA8-AFC5-F7106B3AE3F0

Q35847032-E7C96B8D-92D5-4A24-B0EF-991910380624

Q35847032-EEE273C5-A15A-4162-ABF8-591E3891490D

P577

Q35847032-3EF92589-3852-40E5-9111-01674F88C9F2

P5875

Q35847032-1F8B8D9F-509C-4D72-9FBD-FC8D6D2518C2

P698

Q35847032-F2DE9896-2766-4C76-86AE-667CB3F04143

P932

Q35847032-9F42A8B9-681C-4E86-A5B5-D59761AA4063

P356

JOURNAL.PPAT.1005276

P1433

P1476

Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.

@en

P2093

Bruno Coutard

http://www.w3.org/2001/XMLSchema#string

Daniel D Pinschewer

http://www.w3.org/2001/XMLSchema#string

Dorothée Rigo

http://www.w3.org/2001/XMLSchema#string

Giovanni Magistrelli

http://www.w3.org/2001/XMLSchema#string

Jan Ter Meulen

http://www.w3.org/2001/XMLSchema#string

Lukas Flatz

http://www.w3.org/2001/XMLSchema#string

Mehmet Sahin

http://www.w3.org/2001/XMLSchema#string

Melissa M Remy

http://www.w3.org/2001/XMLSchema#string

Nadia Rabah

http://www.w3.org/2001/XMLSchema#string

Nicolas Fischer

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a new vaccine for the prevention of Lassa fever.

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

Jalview Version 2--a multiple sequence alignment editor and analysis workbench

Emergence of Zaire Ebola Virus Disease in Guinea

Advanced vaccine candidates for Lassa fever

Junín virus pathogenesis and virus replication

Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa

Impaired antibody response causes persistence of prototypic T cell-contained virus

Antigenic properties of the arenaviruses

P304

e1005276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1005276

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Bergthaler

Thomas A. Bowden

Rami Sommerstein

Claire-Anne Siegrist

P577

2015-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284278180

http://www.w3.org/2001/XMLSchema#string

P698

26587982

http://www.w3.org/2001/XMLSchema#string

P932

4654586

http://www.w3.org/2001/XMLSchema#string